Perimenopause
Also known as: Menopause transition, Premenopause
Perimenopause is the transitional phase leading up to menopause, when the ovaries gradually produce less estrogen and hormone levels fluctuate unpredictably. It typically begins in a woman's 40s — though it can start in the late 30s — and lasts an average of four years, ending 12 months after the final menstrual period. During this time, irregular cycles, hot flashes, sleep problems, and mood changes are common. Although perimenopause is a natural stage of life rather than a disease, its symptoms can be disruptive and are very treatable.
Last updated October 31, 2026
Understanding Perimenopause
Perimenopause is the stretch of years, usually four but anywhere from a few months to a decade, when the ovaries begin to run low on follicles and hormone production turns erratic before it finally falls. It is less a slow fade than a storm: oestrogen in early perimenopause is often higher than it was in your thirties, swinging wildly from cycle to cycle, while progesterone drops because ovulation becomes patchy. That combination explains why the first signs are often not hot flushes at all but heavier or closer periods, worse premenstrual symptoms, new anxiety, waking at 3 a.m., and a sense that your usual coping has stopped working, typically in the early to mid forties.
The sequence in the body starts with a shrinking pool of follicles. The brain's pituitary responds by releasing more follicle-stimulating hormone (FSH) to recruit what remains, which can over-stimulate a follicle and push oestrogen above normal, then produce cycles where no egg is released and no progesterone is made. Progesterone is calming (its metabolite allopregnanolone acts on GABA receptors), so its loss shows up as irritability, anxiety and broken sleep, while unopposed oestrogen thickens the uterine lining and drives heavy bleeding. Later in the transition oestrogen declines, cycles lengthen and skip, and hot flushes and vaginal dryness take over. Because levels can change within days, a single FSH or oestradiol blood test rarely settles the diagnosis; the pattern of symptoms and cycle changes does.
Perimenopause ends with menopause, twelve months after the final period, after which symptoms generally stabilise and then slowly recede. Conventional care follows the symptom. For heavy or chaotic bleeding and contraception, a combined hormonal contraceptive, a progestogen-releasing intrauterine device or cyclical oral progesterone regulate the lining and can be continued to around age 50. For hot flushes, sleep and mood tied to the transition, menopausal hormone therapy can be started during perimenopause, not just after periods stop, and oral micronised progesterone at night often improves sleep in its own right. Antidepressants (certain SSRIs and SNRIs) treat both flushes and mood, and cognitive behavioural therapy has good trial data for sleep and the distress of flushes. Heavy bleeding that soaks through protection hourly, bleeding between periods or any bleeding after menopause needs investigation, not supplements.
No natural approach has strong evidence in perimenopause specifically; most trials recruit postmenopausal women and the perimenopause data are a handful of small randomised studies. Ranking them honestly, black cohosh has the most trials but a null pooled result; chaste tree (vitex) has reasonable evidence for premenstrual mood and breast symptoms, which are often what worsens in early perimenopause, and one small placebo-controlled trial in menopausal symptoms; one 8-week RCT of ashwagandha was positive; EPA omega-3 reduced flushes in one trial and depressive symptoms in another. Magnesium and vitamin B6 rest on sleep and PMS data rather than perimenopause trials. These fit as first options for mild cycle-related mood and sleep symptoms, and as adjuncts when hormones are not wanted or not yet needed. They do not treat heavy bleeding or bone loss.
What most people get wrong is assuming perimenopause means low oestrogen and treating it that way, or dismissing it because periods are still coming. The early years are often a high-oestrogen, low-progesterone state, which is why oestrogen-containing supplements or unopposed oestrogen can worsen bleeding and breast tenderness in that phase, and why progesterone-based strategies, sleep protection and stress management help more than people expect. Symptoms that start in your early forties and track with your cycle deserve to be named for what they are, and treated on that basis rather than waited out.
At a Glance
- Common symptoms
- Irregular menstrual periods (shorter, longer, heavier, or skipped), Hot flashes and night sweats, Sleep disturbances and insomnia
- Main treatments
- Menopausal hormone therapy for moderate-to-severe symptoms, Low-dose vaginal estrogen for dryness and urinary symptoms, Non-hormonal medications for hot flashes (certain SSRIs/SNRIs, gabapentin)
- Category
- Reproductive · A universal transition experienced by women, typically beginning in the 40s
- See a doctor if
- Very heavy bleeding, bleeding that lasts longer than usual, or bleeding between periods
Symptoms
Causes
- Natural decline and fluctuation of ovarian estrogen and progesterone production
- Aging of the ovarian follicle reserve
- Changing feedback between the ovaries, pituitary, and hypothalamus
Risk Factors
- Age (most commonly the 40s)
- Smoking, which can bring on the transition earlier
- Family history of early menopause
- Prior chemotherapy or pelvic radiation
- Surgery affecting the ovaries
Diagnosis
- Evaluation of symptoms and menstrual cycle pattern (the primary basis for diagnosis)
- Review of age and medical history
- Blood tests for FSH and estradiol in selected cases (levels fluctuate and are not always definitive)
- Thyroid testing to rule out other causes of similar symptoms
Treatment
- Menopausal hormone therapy for moderate-to-severe symptoms
- Low-dose vaginal estrogen for dryness and urinary symptoms
- Non-hormonal medications for hot flashes (certain SSRIs/SNRIs, gabapentin)
- Lifestyle measures: regular exercise, sleep hygiene, limiting alcohol and caffeine
- Cognitive behavioral therapy for mood and sleep
- Evidence-supported herbal options such as black cohosh for some women
Natural remedies for perimenopause: what the evidence says
Ranked by the strength of human evidence for perimenopause specifically. These sit alongside medical care, not in place of it.
Black Cohosh
Moderate evidenceBlack cohosh has 16 randomised trials, mostly 40 mg/day of a standardised extract for 12 weeks, including several in perimenopausal women. Some found fewer and milder hot flushes and better sleep, but the 2012 Cochrane review found no significant overall difference from placebo, and a 2009 trial combining it with St John's wort in late-perimenopausal women was also negative for flushes. Expect a modest effect at best, visible by 8 to 12 weeks.
- Studied dose
- 20 mg of a standardised isopropanolic extract twice daily (40 mg/day) for an 8 to 12 week trial.
- Cautions
- Rare liver injury has been reported; stop with dark urine, jaundice or right-sided abdominal pain and avoid with liver disease. Not for pregnancy or breastfeeding, and discuss with an oncologist if you have had breast cancer.
Vitex (Chaste Tree Berry)
Moderate evidenceVitex acts on the pituitary to lower prolactin and support luteal progesterone, matching the early-perimenopause pattern of patchy ovulation and worse premenstrual symptoms. In a 170-woman RCT, 20 mg/day halved premenstrual irritability, mood swings and breast tenderness in 52 percent of users versus 24 percent on placebo. In an 8-week placebo-controlled trial of 52 women with menopausal symptoms, 40 mg reduced Greene Climacteric Scale scores, especially anxiety and vasomotor items.
- Studied dose
- 20 to 40 mg/day of a standardised dried fruit extract each morning, continuously for at least 3 cycles.
- Cautions
- May interfere with dopamine agonists and antagonists (bromocriptine, metoclopramide, antipsychotics) and theoretically with hormonal contraceptives and hormone therapy. Stop if pregnancy is confirmed and avoid with a history of hormone-sensitive cancer.
Omega-3 (EPA/DHA)
Preliminary evidenceIn a Canadian double-blind RCT of 120 women in the menopause transition with psychological distress, 1 g/day of EPA for 8 weeks reduced daily hot flushes from 2.8 to 1.6 versus 2.8 to 2.1 on placebo and improved depressive symptoms in those with mild depression, though overall distress scores did not differ. The larger MsFLASH trial in mostly postmenopausal women found no effect on flushes. The signal for mood is more consistent than for flushes.
- Studied dose
- 1 g/day EPA, or 1 to 2 g/day combined EPA and DHA, with food for at least 8 weeks.
- Cautions
- Increases bleeding tendency with warfarin, DOACs and aspirin and can worsen heavy perimenopausal periods at high doses; tell your surgeon before procedures. Use a purified product if pregnancy is possible.
Ashwagandha
Preliminary evidenceA double-blind RCT of 91 perimenopausal women given 300 mg of standardised root extract twice daily for 8 weeks found significantly greater improvement in total Menopause-Specific Quality of Life scores than placebo, with gains in the vasomotor, psychosocial and sexual domains, a rise in oestradiol and a fall in FSH and LH. It is one manufacturer-funded trial, but it is consistent with ashwagandha's better-replicated effects on cortisol, anxiety and sleep.
- Studied dose
- 300 mg of a standardised root extract twice daily with food for 8 weeks.
- Cautions
- Rare liver injury has been reported; stop if jaundice develops. Can raise thyroid hormone levels (relevant with levothyroxine or hyperthyroidism), may add to sedatives, and should be avoided in pregnancy.
Magnesium Glycinate
Preliminary evidenceThere are no perimenopause-specific magnesium trials; the case rests on sleep and premenstrual data. In an 8-week RCT, 500 mg/day magnesium improved insomnia severity, sleep time and early waking versus placebo, and in PMS trials 250 to 360 mg/day reduced mood symptoms and fluid retention, especially combined with vitamin B6. Glycinate is well absorbed and gentle, which matters when gut symptoms are already part of the picture.
- Studied dose
- 200 to 400 mg elemental magnesium as glycinate in the evening, continuously.
- Cautions
- Reduce or avoid with kidney impairment; separate from quinolone and tetracycline antibiotics and from levothyroxine by 2 to 4 hours. Diarrhoea means too much.
Vitamin B6
Preliminary evidenceVitamin B6 is a cofactor for serotonin, dopamine and GABA synthesis. A BMJ systematic review of 9 trials (940 women) found doses up to 100 mg/day roughly doubled the odds of overall premenstrual symptom improvement and of improvement in depressive symptoms, though trial quality was low. For perimenopausal mood specifically there are no controlled trials, so its use is an extrapolation from PMS data.
- Studied dose
- 50 to 100 mg/day pyridoxine, or 25 to 50 mg/day as pyridoxal-5-phosphate, with food; do not exceed 100 mg/day.
- Cautions
- Doses above 100 mg/day taken for months can cause sensory neuropathy (numbness, tingling) that is sometimes slow to reverse. Reduces the effect of levodopa unless combined with carbidopa; safe in pregnancy at ordinary doses.
What matters day to day
- Keep a cycle and symptom diary for three months: because hormone tests swing day to day, a diary is the most reliable diagnostic tool and shows whether symptoms track the luteal phase, which changes treatment.
- Protect a fixed sleep window and treat night sweats early: in the SWAN study, difficulty sleeping affected 38 percent of perimenopausal women and predicted worse mood, so sleep is a cause as well as a symptom.
- Limit alcohol, especially in the evening: it triggers flushes, fragments the second half of the night when progesterone-driven sleep is already weaker, and worsens heavy bleeding through its effect on oestrogen metabolism.
- Build resistance training into most weeks: bone loss can begin a year or two before the final period and runs at 1 to 2 percent a year across the transition; loading bone and muscle now is the cheapest protection.
- Check iron if periods are heavy: perimenopausal flooding is a common cause of iron deficiency, and fatigue, brain fog and poor exercise tolerance blamed on hormones are often low ferritin.
Prevention
- Perimenopause is a natural transition and cannot be prevented
- Symptom severity may be reduced by not smoking
- Staying physically active and maintaining a healthy weight
- Prioritizing sleep and stress management
When to See a Doctor
- Very heavy bleeding, bleeding that lasts longer than usual, or bleeding between periods
- Periods that come very close together
- Any vaginal bleeding after menopause
- Symptoms that significantly affect your quality of life
- Mood changes that feel overwhelming or persistent
Frequently Asked Questions
References
- Harlow SD, Gass M, Hall JE, et al.. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause (2012)
- The 2022 hormone therapy position statement of The North American Menopause Society. Menopause (2022)
- Gopal S, Ajgaonkar A, Kanchi P, et al.. Effect of an ashwagandha (Withania somnifera) root extract on climacteric symptoms in women during perimenopause: a randomized, double-blind, placebo-controlled study. Journal of Obstetrics and Gynaecology Research (2021)
- Lucas M, Asselin G, Mérette C, Poulin MJ, Dodin S. Ethyl-eicosapentaenoic acid for the treatment of psychological distress, depressive symptoms, and hot flashes in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial. American Journal of Clinical Nutrition (2009)
- van Die MD, Burger HG, Teede HJ, Bone KM. Hypericum perforatum with Vitex agnus-castus in menopausal symptoms: a randomized, controlled trial. Menopause (2009)
- Naseri R, Farnia V, Yazdchi K, Alikhani M, Basanj B, Salemi S. Comparison of Vitex agnus-castus extracts with placebo in reducing menopausal symptoms: a randomized double-blind study. Korean Journal of Family Medicine (2019)
- Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database of Systematic Reviews (2012)
- Wyatt KM, Dimmock PW, Jones PW, O'Brien PM. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ (1999)
- Abbasi B, Kimiagar M, Sadeghniiat K, Shirazi MM, Hedayati M, Rashidkhani B. The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial. Journal of Research in Medical Sciences (2012)
- Menopause: symptoms, diagnosis and treatment. NHSView source
Related Conditions
Evidence-graded guides
Related from the Supplement Library
Black Cohosh
ModerateHerb · Reduces menopausal hot flashes
Vitex (Chaste Tree Berry)
ModerateHerb · Reduces PMS symptoms
Magnesium Glycinate
StrongMineral · Improves sleep quality and onset
Saffron
ModerateHerb · Improves mild-to-moderate depressive symptoms
Maca Root
ModerateHerb · Supports libido and sexual function
These supplements have been studied in relation to Perimenopause. Always consult your healthcare provider before starting any supplement, especially if you take medications.
Related Reading
Have questions about Perimenopause?
Ask Mother Nature AI for personalized, evidence-based guidance.
Ask about PerimenopauseMedical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.
Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.